-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Approves Durvalumab With Enfortumab Vedotin-Ejfv For Muscle-Invasive Bladder Cancer

Benzinga·11/13/2026 18:30:05
Listen to the news